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The blood-red sap of Dragon's blood has been used in folk medicine for fractures, wounds, inﬂammation,
gastrointestinal disorders, rheumatism, blood circulation dysfunctions, and cancer. Existing in vitro and
in vivo bioactivity of this herb on different mechanisms of healing shows strong potential of this sap in
wound healing. This clinical trial study was designated to evaluate the wound healing effect of Dragon's
blood on human wounds. Sixty patients, between the ages of 14e65 years, who were referred to remove
their skin tag, were assigned to this double-blind, placebo-controlled, randomized clinical trial and
received either Dragon's blood or a placebo cream. They were visited on the 3rd, 5th, 7th, 10th, 14th, and
20th day of the trial to check the process of healing and to measure the wound's surface. At the end of
trial, there was a signiﬁcant difference in the mean duration of wound healing between the two groups
(p ¼ 0.0001). The phenolic compounds and the alkaloid taspine, which exist in Dragon's-blood resin, are
probably the main reasons for the wound healing property of this plant. Being natural accessible, safe,
and affordable makes Dragon's blood cream, a good choice for addition to the wound healing arma-
mentarium. Further studies on wounds with different causes and among larger populations are sug-
gested to ensure the effectiveness and safety of Dragon's blood.
Copyright © 2014, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Dragon's blood, a deep red resin, is a well-known traditional
medicine, obtained from four different sources: Croton spp. (syn.
Sangre de draco, Euphorbiaceae), Dracaena spp. (syn. Zanzibar
drop, Dracaenaceae), Daemonorops spp. (syn. Jerang or Djerang,
Palmaceae), and Pterocarpus spp. (syn. East India Kino or Malabar
Kino, Fabaceae). Dragon's blood has been used by different civili-
zations such as the Greeks, the Romans, and the Arabs.1 Croton
lechleri has several medicinal properties, such as wound healing,1,2
cicatrizant,3 immunomodulator,1,4 analgesic, antiulcer,t, School of Pharmacy, Ahvaz
Ave., Ahvaz, Iran.
an@yahoo.com (F. Namjoyan).
for Food and Biomolecules,
molecules, National Taiwan Univeantidiarrheal,1 antibacterial,5 antiviral,6 antihemorrhagic,1 anti-
inﬂammatory, antioxidant,1,3 mutagenic and antimutagenic,1,3,7
antitumor,1,8 anticancer,9 and cytotoxic effects.1,3 Proanthocyani-
dins are the main chemical constituent of the resin, >90% of the dry
weight.10 It also contains taspin, an alkaloid, and catechin, epi-
galocatechin, epicatechin, and a small percentage of terpene
compounds.11,12
Wounds, the physical damage to the skin and its underlying
structure, can result from trauma, burns, or chemicals.13 Wound
healing is a complicated process. According to cellular and molec-
ular mechanisms, there are three overlapping phases of wound
healing as follows: inﬂammation due to themigration of ﬁbroblasts
and inﬂammatory cells, such as neutrophils and monocytes, into
the wound site; then, reconstruction of the epithelial barrier and
production matrix at the site of injury leading to new tissue for-
mation; and ﬁnally, maturation.14e16rsity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Tannic acid Standard curve in measurement of total phenolic content using
Folin- Ciocaltue method.
Fig. 2. Measurement of total phenolic content of C. lechleri using Folin- Ciocaltue
method.
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ence on complement system.4 The antioxidant agents from
Dragon's blood leaves and fruit, such as phenolic proﬁle and
organic acids, are able to protect against free radicals.17,18 Note-
worthy, the anti-inﬂammatory effect of the alkaloid taspine has
been reported.19 These studies have shown this plant can promote
healing by affecting the inﬂammatory phase. Studies conﬁrm that
after only 1 day of treatment with Dragon's blood, the wound
contracts and a dark crust forms on the wound surface which
prevents secondary infection.2,20 It also stimulates the proliferation
and migration of ﬁbroblasts and the production of collagen,
resulting in epithelial regeneration and wound healing which can
affect second and third phases of the healing process.2,12
Although there are some studies addressing the healing effect of
Dragon's blood on cell lines in animal models,2,20,27 to best of our
knowledge, the effect on human skin has not been studied yet. In
this study, we designated to evaluate the healing effect of Dragon's
blood on human skin.
2. Materials and methods
2.1. Trial design
This double-blind, placebo-controlled, randomized clinical trial
was conducted on 60 patients referred to the dermatology clinic of
Imam Khomeini Hospital (Ahvaz Jundishapur University of Medical
Sciences, Ahvaz, Iran.) for the removal of their skin tags between
October 2010 to November 2011. Written consent was obtained
from all participants. The trial was registered by the IRCT Iranian
Registry of Clinical Trials (IRCT201008224610N1), in accordance
with the Helsinki Declaration of 1975, and was conﬁrmed by the
Ethics Committee of Ahvaz Jundishapur University of Medical Sci-
ences (Eth NO. 715).
The patients, aged between 14 years and 65 years, were referred
for skin tag removal using cautery. Inclusion criteria were lesions
between 3 mm and 10 mm in diameter and exclusion criteria were
uncontrolled or chronic diseases, pregnancy, or breastfeeding. De-
mographic characteristics such as sex, age, and skin type, and
number and anatomical area of lesions were recorded in the
questionnaire. After measuring the wound's surface using check-
ered transparent paper (the surface of each square was 1 mm2), a
therapeutic or placebo cream was given to the patients randomly
(according to block method randomization). All patients were
asked to use the cream twice a day and store it at room tempera-
ture. They were also asked not to use any other medicament for
wound healing. The wound's surface and recovery was considered
100% and 0%, respectively, on the 1st day. The patients were visited
on the 3rd, 5th, 7th,10th,14th, and 20th day of the trial to check the
healing process and to measure the wound's surface. If recovery
was not 100% on the 20th day, they were followed up until the
wound's surface and recovery were 0% and 100%, respectively.
2.2. Plant material
Croton lechleri powder was purchased from the Maya Ethno-
botanicals, Harleem, Netherland Company. Extraction was per-
formed using a Soxhlet apparatus with ethanol (80%) for 4 hours,12
and was then ﬁltrated and concentrated using a rotary evaporator
(Heidolph, Germany). Finally, the extract was dried in a freeze drier
(Operon, Korea).
2.3. Phytochemical study
Total phenolic content was determined using the Folin-
Ciocaltue method.21 Brieﬂy, to 0.5 mL of each sample (tannic acidas positive standard or extract) 2.5 mL 1/10 diluted FolineCiocalteu
reagent was added. After 5 minutes, 2 mL of Na2CO3 (7.5% w/v) was
added and incubated at room temperature in a dark place for 2
hours. The absorbance of all samples was measured at 765 nm. The
results were expressed as g of tannic acid equivalent/100 g of dry
extract powder.
2.4. Preparation of Dragon's blood cream
The formulation was as follows: 10% cetyl alcohol, 7% iso-
propylmeristat, and 21% Vaseline(cream base); 1.5% span20 and
1.5% tween80 (emulsifying agent); 0.02% propylparaben and 0.18%
methylparaben (preservative); 5% propylene glycol (humectant);
15% ethanolic extract of C. lechleri, and distilled water.
The same ingredients were used to prepare the placebo cream
with the exception of the herbal extract. Permitted food colors were
used to achieve the color of the therapeutic cream (reddish brown).
Similar tubes were ﬁlled with the therapeutic and placebo cream
and labeled. Both creams were differentiated using codes that were
unknown to the participants and researcher.
2.5. Statistical analysis
The data were expressed as mean ± standard deviation and
analyzed using the two-tailed Student t test to compare the mean
duration of wound healing between the two groups and the per-
centage of wound healing per day, and the analysis of variance
(ANOVA) method was used to compare the mean duration of
healing between different anatomical areas. A value of p < 0.05 was
considered signiﬁcant.
3. Results
The presence of alkaloid was conﬁrmed by black spot in Dra-
gandrof, and cream and brown precipitation in Mayer and Wagner
reagents, respectively.
Fig. 3. Number of wounds in studied population.
Table 3
The mean percentage of wound healing in different days for two groups.
3rd day 5th day 7th day 10th day 14th day
Therapeutic 31.06% 63.77% 77.80% 89.14% 95.73%
Placebo 4.74% 23.50% 43.90% 61.95% 78.10%
P value 0.0001 0.0001 0.0001 0.0001 0.004
F. Namjoyan et al. / Journal of Traditional and Complementary Medicine 6 (2016) 37e40 39Total phenolic content was measured using the FolineCiocalteu
method and tannic acid was used as a positive standard (Figs. 1
and 2).
Tannic acid equivalent in 100 g Dragonʼs blood powder was
6.632 ± 0.65 g, and in 100 g dry extract was 43.35 ± 4.27 g. The
prepared cream contained 15% extract, therefore, it included
6.5025 g total phenolic compounds.
Sixty participants (31 women and 29men) entered into the trial.
Eighteen patients had one wound, 26 patients had two wounds,
and 16 patients had three wounds (Fig. 3). We investigated 100
wounds in total. Forty-ﬁve wounds were assigned to the thera-
peutic group and 55 wounds were assigned in the placebo group
randomly. Thirty-eight wounds (63.34%) were on the neck, 20
wounds (43.33%) were on the trunk, and 16 wounds (26.67%) were
on the lower limbs. There were no signiﬁcant differences between
the two groups for age (p ¼ 0.799) and wound surface (p ¼ 0.946)
before starting the study (Tables 1 and 2). Twelve patients (17
wounds) had poor compliance and withdrew from the study. There
were no irritations or wound infections among the therapeutic
participants, whereas one patient in the placebo group showed
wound infection, and was treated with mupirocin topical ointment
and dropped out of the study. Eventually, the trial was completed
with 37 wounds in the therapeutic group and 46 wounds in the
placebo group.
Two-tailed Student t test was used to compare the mean dura-
tion of healing and the percentage of wound healing between the
two groups. The differences in the percentage of wound healing
between the two groups were signiﬁcant on all days of the trial
(Table 3).
To compare the mean duration of healing between different
anatomical areas, the ANOVA test was used. There were no signif-
icant differences between anatomical areas in both groups
(p > 0.05).Table 1
Comparison of mean age between two groups before starting the study.
Group Mean of age SD P value
Therapeutic 38.4 10.98 0.799
Placebo 48.96 10.99 0.799
Table 2
Comparison of wound's surface between two groups before starting the study.
Group Number of wounds Mean of wound's surface SD P value
Therapeutic 45 8.54 4.1 0.946
placebo 55 8.6 4.048 0.9464. Discussion
The results of this clinical trial showed that Dragon's blood
cream can signiﬁcantly improve the wound healing duration
(p ¼ 0.0001).
Previous studies reported the antioxidant and anti-
inﬂammatory effects of Dragon's blood sap.1,3,22 It is also reported
to inhibit the lipid peroxidation in the liver of mice.23 In this study,
we observed a signiﬁcant improvement of wound healing from the
3rd day, which may be due to a shortening of the inﬂammation
process because of the presence of phenolic compounds such as
proanthocyanidins and catechin.1,20
Our results are in agreement with two studies which investi-
gated the healing effect of Dragon's blood on rats. One of these
studies showed the wound healing effect of the alkaloid taspine in
rats. It suggested taspine stimulated chemotaxis of ﬁbroblasts.24
Another study showed the wound healing activity of Dragon's
blood was because of the high percentage of polyphenolic com-
pounds in this plant.1,2
Inﬂammation is usually a suitable media for infections, and
healing is delayed in these situations.25 The polyphenolic com-
pounds of the sap create a protective layer on the wound surface,
and this physical barrier prevents microbial contamination. Some
compounds of the resin, 2,4,6-trimethoxyphenol, 1,3,5-trimethox-
ybenzene, crolechinic acid, and korberin, which showed antibac-
terial effects, can indirectly improve the healing process.1,20
Wound contraction is one of the factors that facilitates re-
epithelialization.25 The polyphenolic compounds condense and
clog the wounds by binding to proteins, and enzymes lead to
ailment.20 Froldi et al26 have suggested that the vasoconstriction
effect of Dragon's blood affects wound healing probably by
fastening the wound.
Angiogenesis and matrix reformation phases occur after re-
epithelialization. The migration and proliferation of ﬁbroblasts
causes reformation of the matrix.25 Dragon's blood sap probably
affects wound healing through increasing the migration of human
ﬁbroblasts in the cell culture and proliferation of the endothelial
cells.12,24
5. Conclusion
This clinical trial suggests Dragon's blood is a potent, available,
affordable, and safe healing agent. The exact role of Dragon's blood
in the pathogenesis of wound healing regarding its effect on
stimulation or hindering mediator's synthesis is still absent and
further studies are required. Our study encourages evaluating the
healing process on other wounds such as diabetic ulcers, bedsores,
or burns.
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